Editorial: Recurrent pregnancy loss and endocrine dysfunction.

Zhang H, Lianghui Diao
Frontiers in endocrinology · 2024 · doi:10.3389/fendo.2024.1453336 · PMID:39045275 · PMC11263332
OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash+body, 2026-08-14 ⓘ

This editorial reviews studies on recurrent pregnancy loss to highlight the multifaceted relationship with endocrine dysfunction and emphasize comprehensive endocrine evaluations for improved clinical outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-14 · read from full text ⓘ

This editorial summarizes a collection of studies exploring the complex link between endocrine dysfunction and recurrent pregnancy loss. The authors emphasize the necessity for comprehensive, individualized endocrine evaluations in women experiencing RPL to enhance clinical outcomes. They aim to reduce the burden of this condition on families by improving reproductive health practices through better understanding and management strategies. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 830 characters · extracted from pmc-nxml · 2 sections · click to expand

Conclusions

In conclusion, these studies collectively enhance our understanding of the multifaceted relationship between endocrine dysfunction and RPL. They underscore the importance of comprehensive and individualized endocrine evaluations in women with RPL to improve clinical outcomes. The knowledge gained from this compilation of studies aims to reduce the burden of RPL on affected women and their families, ultimately leading to better clinical practices and improved reproductive health outcomes. We express our gratitude to all contributors for their invaluable research and to the reviewers for their critical evaluations. We hope this Research Topic will stimulate further research and enhance clinical practices in managing endocrine-related recurrent pregnancy loss.

Author Contributions

HZ: Writing – review & editing. LD: Writing – original draft.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-20T09:27:46.357103+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC